ACC 2026: Top Takeaways from the 2026 Dyslipidaemia Guidelines

14 Visioni
Published
Dr Ann Marie Navar (UT Southwestern, US) delivers an expert breakdown of the most clinically impactful updates from the 2026 Dyslipidaemia Guidelines.

Join Dr Navar as she navigates the key recommendations shaping the future of lipid management, exploring what the updated guidance means for patient risk stratification, treatment targets, and real-world practice.

Editor: Jordan Rance
Videographer: David Ben-Harosh, Dan Brent

Support: This is an independent video produced by Radcliffe Cardiology.

Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook: https://www.facebook.com/RadcliffeCardiology
Follow us on X: https://x.com/radcliffeCARDIO
Categoria
Cardiology
Commenta per primo questo video.